Table 3.

Total (inpatient + outpatient) direct medical costs of care for subjects with GCA over a 5-year period. Values are the total incremental costs (95% CI) according to cost-percentiles for patients with GCA compared with referent subjects, inflation-adjusted to 2014 US dollars compared with referent subjects.

PercentileModel 1*Model 2
10th2679 (968–4072)1018 (82–1973)
25th2909 (1135–5016)1400 (−865 to 3167)
50th6351 (422–10,486)3576 (635–6140)
75th5431 (−6156 to 19302)6012 (2258–10,136)
90th−7187 (−34,065 to 16,335)7530 (−124 to 14,216)
  • * Adjusted for age and sex.

  • Adjusted for age, sex, weighted Charlson Comorbidity Index, and number of inpatient days. GCA: giant cell arteritis.